Suppr超能文献

糖尿病视网膜病变的发病和进展:系统评价。

Incidence and progression of diabetic retinopathy: a systematic review.

机构信息

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore.

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

出版信息

Lancet Diabetes Endocrinol. 2019 Feb;7(2):140-149. doi: 10.1016/S2213-8587(18)30128-1. Epub 2018 Jul 11.

Abstract

Diabetic retinopathy is a leading cause of vision impairment and blindness. We systematically reviewed studies published from Jan 1, 1980, to Jan 7, 2018, assessed the methodological quality, and described variations in incidence of diabetic retinopathy by region with a focus on population-based studies that were conducted after 2000 (n=8, including two unpublished studies). Of these eight studies, five were from Asia, and one each from the North America, Caribbean, and sub-Saharan Africa. The annual incidence of diabetic retinopathy ranged from 2·2% to 12·7% and progression from 3·4% to 12·3%. Progression to proliferative diabetic retinopathy was higher in individuals with mild disease compared with those with no disease at baseline. Our Review suggests that more high-quality population-based studies capturing data on the incidence and progression of diabetic retinopathy with stratification by age and sex are needed to consolidate the evidence base. Our data is useful for conceptualisation and development of major public health strategies such as screening programmes for diabetic retinopathy.

摘要

糖尿病视网膜病变是导致视力损害和失明的主要原因。我们系统地回顾了 1980 年 1 月 1 日至 2018 年 1 月 7 日发表的研究,评估了研究方法的质量,并描述了按地区划分的糖尿病视网膜病变发病率的变化,重点关注 2000 年后进行的基于人群的研究(n=8,包括两项未发表的研究)。这八项研究中,有五项来自亚洲,一项来自北美、加勒比地区和撒哈拉以南非洲。糖尿病视网膜病变的年发病率范围为 2.2%至 12.7%,进展率为 3.4%至 12.3%。与基线时无疾病的个体相比,轻度疾病患者的增生性糖尿病视网膜病变进展率更高。我们的综述表明,需要更多高质量的基于人群的研究,这些研究应通过年龄和性别分层来收集糖尿病视网膜病变发病率和进展的数据,以巩固证据基础。我们的数据对于制定重大公共卫生战略(如糖尿病视网膜病变筛查计划)具有重要的概念和发展作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验